Interest in psychedelic-assisted therapy has grown rapidly as researchers continue studying treatments such as psilocybin, MDMA, and ketamine for a variety of mental health conditions.
However, one of the most important things to understand is that these therapies are not appropriate for everyone.
Determining whether someone may be a good candidate requires a comprehensive medical and psychological evaluation. Factors such as diagnosis, medical history, current medications, and overall mental health all play an important role in deciding whether psychedelic-assisted therapy may be appropriate.
What Makes Someone a Good Candidate?
Although researchers continue to study who benefits most, potential candidates often share several characteristics:
- They have a diagnosed mental health condition being studied in clinical research.
- Evidence-based treatments have provided limited benefit or unacceptable side effects.
- They have realistic expectations about what treatment can—and cannot—accomplish.
- They are willing to participate in psychotherapy before, during, and after treatment when appropriate.
- They are medically and psychologically stable enough to participate safely.
Importantly, psychedelic-assisted therapy is not viewed as a “quick fix.” These treatments are designed to be part of a broader therapeutic process rather than a standalone intervention.
Why Expectations Matter
One of the strongest predictors of a positive therapeutic experience is entering treatment with realistic expectations.
Psychedelic-assisted therapy is not intended to:
- Instantly eliminate depression or anxiety
- Erase traumatic memories
- Permanently change someone’s personality
- Replace ongoing mental health care
Instead, researchers believe these treatments may help create opportunities for emotional processing, increased psychological flexibility, and meaningful therapeutic work when combined with professional support.
Comprehensive Medical Screening
Before participating in psychedelic-assisted therapy or a clinical trial, individuals typically undergo an extensive medical evaluation.
This screening may include:
- Medical history
- Current health conditions
- Heart and cardiovascular health
- Blood pressure assessment
- Previous neurological conditions
- Review of current medications
The purpose is to identify factors that could increase the risks associated with treatment.
A Thorough Psychiatric Evaluation
Equally important is a detailed psychiatric assessment.
Mental health professionals evaluate:
- Current psychiatric diagnoses
- Previous treatment history
- Hospitalizations
- Suicide risk
- Trauma history
- Substance use history
- Family history of psychiatric illness
This evaluation helps determine whether psychedelic-assisted therapy is appropriate and whether additional treatment may be needed before considering these therapies.
Bipolar Disorder May Require Additional Caution
Individuals with bipolar disorder require careful evaluation before participating in psychedelic-assisted therapy.
Researchers continue studying how psychedelic treatments may affect mood disorders, but concerns remain that certain therapies could increase the risk of triggering manic or hypomanic episodes in susceptible individuals.
For this reason, many clinical trials either exclude individuals with bipolar disorder or apply additional screening requirements.
Psychosis Is an Important Consideration
A personal or family history of psychotic disorders is another important factor.
Many research studies exclude individuals with conditions such as schizophrenia or schizoaffective disorder because psychedelic experiences may increase the risk of worsening psychotic symptoms.
This does not mean every individual faces the same level of risk, but it underscores why professional evaluation is essential before pursuing treatment.
Substance Use History
A history of substance use does not automatically disqualify someone from psychedelic-assisted therapy.
However, clinicians will carefully evaluate factors such as:
- Current substance use
- Recovery status
- Previous treatment history
- Risk of relapse
- Overall stability
Some psychedelic therapies are being studied for substance use disorders themselves, while active substance misuse may increase risks in other situations.
Every case requires individualized assessment.
Physical Health Matters Too
Mental health is only one part of the evaluation.
Certain physical health conditions may influence whether psychedelic-assisted therapy is appropriate, including:
- Cardiovascular disease
- Uncontrolled hypertension
- Certain neurological conditions
- Pregnancy
- Other medical conditions that could increase treatment risk
Medical screening helps ensure patient safety throughout the treatment process.
Current Medications Can Affect Treatment
Many psychiatric medications interact with brain systems involved in psychedelic therapies.
Depending on the treatment being studied, clinicians may review medications such as:
- Antidepressants
- Mood stabilizers
- Antipsychotic medications
- Anti-anxiety medications
- Stimulants
Patients should never stop prescribed medications on their own. Any medication changes should occur only under the supervision of the prescribing clinician.
Why a Professional Evaluation Is Essential
No online questionnaire or symptom checklist can determine whether psychedelic-assisted therapy is appropriate.
A qualified evaluation considers the whole person, including:
- Medical history
- Mental health diagnosis
- Current symptoms
- Treatment goals
- Safety considerations
- Available treatment options
For some individuals, established evidence-based therapies may remain the best choice. For others, participation in a clinical trial or emerging treatment may eventually become appropriate as research continues.
Looking Ahead
Psychedelic-assisted therapy represents an exciting area of mental health research, but careful patient selection remains one of the most important parts of safe treatment.
These therapies are not appropriate for everyone, and determining who may benefit requires thoughtful medical and psychological evaluation by qualified professionals.
As research continues, clinicians will gain a better understanding of which patients are most likely to benefit and how these treatments can be integrated into comprehensive mental health care.
Learn More About Psychedelic Therapy in California
Whether you’re exploring treatment options or looking for information specific to your region, continue your research with these guides.
Treatment Guides
- MDMA Therapy in California
- Psilocybin Therapy in California
- Ketamine Therapy
- Psychedelic Integration Therapy
- Psychedelic Clinical Trials California
Regional Guides
- Bay Area Psychedelic Therapy Guide
- Los Angeles Psychedelic Therapy Guide
- Orange County Psychedelic Therapy Guide
- San Diego Psychedelic Therapy Guide
- Sacramento Psychedelic Therapy Guide
- San Jose Psychedelic Therapy Guide
- Silicon Valley Psychedelic Therapy Guide
- Inland Empire Psychedelic Therapy Guide
- Central Coast Psychedelic Therapy Guide